Position in SNY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$29,205,846
-$12,555,277 QoQ
Shares Held
684,619
-21.0% QoQ
Ownership
0.029%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#45
of 712 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SNY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NATIXIS ADVISORS, LLC holds $3,560,811,525 across 15 Drug Manufacturers - General names. SNY ranks #12 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
876,181 | $1,050,917,864 | |
| 2 | JNJ |
Johnson & Johnson
|
1,962,221 | $498,345,267 | |
| 3 | ABBV |
AbbVie Inc.
|
1,561,703 | $392,986,942 | |
| 4 | AZN |
Astrazeneca PLC
|
1,978,508 | $375,164,686 | |
| 5 | NVS |
Novartis AG
|
2,386,527 | $374,016,511 | |
| 6 | MRK |
Merck & Co., Inc.
|
2,857,628 | $367,205,197 | |
| 7 | AMGN |
Amgen Inc
|
381,869 | $138,282,402 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
954,962 | $120,649,899 |
All Filings in SNY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $29,205,846 | 684,619 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $41,761,123 | 866,773 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $156,763,787 | 3,234,911 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $146,951,583 | 3,113,381 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $134,582,577 | 2,785,812 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $163,328,868 | 2,944,985 | Shares | Defined | 2025-05-08 | |
| 2024-12-31 | $140,350,312 | 2,910,021 | Shares | Defined | 2025-02-10 | |
| 2024-09-30 | $165,639,742 | 2,874,193 | Shares | Defined | 2024-11-06 | |
| 2024-06-30 | $133,918,111 | 2,760,060 | Shares | Defined | 2024-08-01 | |
| 2024-03-31 | $130,653,664 | 2,688,347 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $122,622,343 | 2,465,762 | Shares | Other | 2024-02-06 | |
| 2023-09-30 | $135,617,421 | 2,528,289 | Shares | Other | 2023-11-13 | |
| 2023-06-30 | $117,595,030 | 2,181,726 | Shares | Other | 2023-08-15 | |
| 2023-03-31 | $108,148,158 | 1,987,287 | Shares | Other | 2023-05-11 | |
| 2022-12-31 | $81,732,162 | 1,687,635 | Shares | Other | 2023-01-27 | |
| 2022-09-30 | $33,239,745 | 874,270 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $74,208,447 | 1,483,279 | Shares | Other | 2022-08-12 | |
| 2022-03-31 | $71,579,510 | 1,394,225 | Shares | Other | 2022-05-12 | |
| 2021-12-31 | $64,072,688 | 1,278,896 | Shares | Other | 2022-02-08 | |
| 2021-09-30 | $57,093,366 | 1,184,264 | Shares | Other | 2021-11-15 | |
| 2021-06-30 | $63,206,323 | 1,200,272 | Shares | Other | 2021-08-12 | |
| 2021-03-31 | $56,510,176 | 1,142,543 | Shares | Other | 2021-05-05 | |
| 2020-12-31 | $50,196,093 | 1,033,054 | Shares | Other | 2021-02-12 | |
| 2020-09-30 | $50,447,991 | 1,005,541 | Shares | Other | 2020-11-12 | |
| 2020-06-30 | $50,443,525 | 988,120 | Shares | Other | 2020-08-11 | |
| 2020-03-31 | $43,974,319 | 1,005,817 | Shares | Other | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||